Tadalafil, the erectile dysfunction drug sold as Cialis, is being promoted in some wellness circles as a possible longevity treatment. NPR reports that research has suggested a link between tadalafil and a lower risk of death in men, which has fueled interest beyond its standard use for erectile dysfunction.
However, the outlets note that the evidence is not definitive. There are no well-controlled human trials establishing that tadalafil directly extends lifespan or improves long-term outcomes. While observational or secondary findings have raised the possibility of benefit, experts and reporting emphasize uncertainty and the lack of rigorous clinical testing.
Taken together, the coverage frames the discussion as early and hypothesis-driven rather than proven. The drug’s potential mechanisms and signals from existing studies are being discussed, but current medical guidance would not treat tadalafil as a validated longevity therapy. Instead, the question remains whether future trials will confirm any survival benefit and identify who, if anyone, might benefit.
